Evidence map›Paper›PMID 31164864›Full record

ArticleFrontiers in endocrinology2019

O-GlcNacylation Links TxNIP to Inflammasome Activation in Pancreatic β Cells.

Gaelle Filhoulaud, Fadila Benhamed, Patrick Pagesy, Caroline Bonner, Yann Fardini, Anissa Ilias, Jamileh Movassat, Anne-Françoise Burnol, Sandra Guilmeau, Julie Kerr-Conte and 3 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in endocrinology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 25 citations in OpenAlex.

  1. Loss of Peroxiredoxin 6 Drives Age-Related Klf9/NF-Antioxidants (Basel, Switzerland) · 2026
    Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Metabolites · 2022
    Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Role ofPhysiological reviews · 2021
    Review
  14. Article
  15. TXNIP/TBP-2: A Master Regulator for Glucose Homeostasis.Antioxidants (Basel, Switzerland) · 2020
    Review
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 1 country.

Gaelle FilhoulaudINSERM U1016, Institut Cochin, Paris, France.
Fadila BenhamedINSERM U1016, Institut Cochin, Paris, France.
Patrick PagesyINSERM U1016, Institut Cochin, Paris, France.
Caroline BonnerPasteur Institute de Lille, Lille, France.
Yann FardiniINSERM U1016, Institut Cochin, Paris, France.
Anissa IliasUMR8251-CNRS, Paris, France.
Jamileh MovassatUMR8251-CNRS, Paris, France.
Anne-Françoise BurnolINSERM U1016, Institut Cochin, Paris, France.
Sandra GuilmeauINSERM U1016, Institut Cochin, Paris, France.
Julie Kerr-ConteINSERM U1190 - EGID, Lille, France.
François PattouINSERM U1190 - EGID, Lille, France.
Tarik IssadINSERM U1016, Institut Cochin, Paris, France.
Catherine PosticINSERM U1016, Institut Cochin, Paris, France.
Inserm · FRUniversité Paris Cité · FREuropean Genomic Institute for Diabetes · FRInstitut Cochin · FRCentre National de la Recherche Scientifique · FRDélégation Paris 5 · FRDélégation Paris 7 · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Thioredoxin interacting protein (TxNIP), which strongly responds to glucose, has emerged as a central mediator of glucotoxicity in pancreatic β cells. TxNIP is a scaffold protein interacting with target proteins to inhibit or stimulate their activity. Recent studies reported that high glucose stimulates the interaction of TxNIP with the inflammasome protein NLRP3 (NLR family, pyrin domain containing 3) to increase interleukin-1 β (IL1β) secretion by pancreatic β cells. To better understand the regulation of TxNIP by glucose in pancreatic β cells, we investigated the implication of O-linked β-N-acetylglucosamine (O-GlcNAcylation) in regulating TxNIP at the posttranslational level. O-GlcNAcylation of proteins is controlled by two enzymes: the O-GlcNAc transferase (OGT), which transfers a monosaccharide to serine/threonine residues on target proteins, and the O-GlcNAcase (OGA), which removes it. Our study shows that TxNIP is subjected to O-GlcNAcylation in response to high glucose concentrations in β cell lines. Modification of the O-GlcNAcylation pathway through manipulation of OGT or OGA expression or activity significantly modulates TxNIP O-GlcNAcylation in INS1 832/13 cells. Interestingly, expression and O-GlcNAcylation of TxNIP appeared to be increased in islets of diabetic rodents. At the mechanistic level, the induction of the O-GlcNAcylation pathway in human and rat islets promotes inflammasome activation as evidenced by enhanced cleaved IL1β. Overexpression of OGT in HEK293 or INS1 832/13 cells stimulates TxNIP and NLRP3 interaction, while reducing TxNIP O-GlcNAcylation through OGA overexpression destabilizes this interaction. Altogether, our study reveals that O-GlcNAcylation represents an important regulatory mechanism for TxNIP activity in β cells.

Indexed as

hyperglycemiainflammasomeO-GlcNAcylationpancreatic beta cellsTXNIP (thioredoxin-interacting protein)

Identifiers

PMID31164864
PMCPMC6536593
OpenAlexW2943281936

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.